A detailed history of Parallax Volatility Advisers, L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 212,600 shares of MRNA stock, worth $14 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
212,600
Previous 48,300 340.17%
Holding current value
$14 Million
Previous $5.15 Million 390.59%
% of portfolio
0.06%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $5.23 Million - $7.86 Million
75,236 Added 361.54%
96,046 $9.55 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $1.45 Million - $1.9 Million
15,016 Added 259.16%
20,810 $2.15 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $683,034 - $925,294
5,764 Added 19213.33%
5,794 $703,000
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $4,069 - $5,910
-30 Reduced 50.0%
30 $4,000
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $24.9 Million - $44.1 Million
-209,940 Reduced 99.97%
60 $10,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $19.1 Million - $31.4 Million
161,888 Added 336.48%
210,000 $24.8 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $667,641 - $1.01 Million
-5,700 Reduced 10.59%
48,112 $6.87 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $6.84 Million - $12.7 Million
-54,086 Reduced 50.13%
53,812 $9.27 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $24.4 Million - $39.8 Million
107,870 Added 385250.0%
107,898 $27.4 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $6,213 - $13,565
28 New
28 $11,000
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $6,213 - $13,565
-28 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $1.64 Million - $2.97 Million
-12,641 Reduced 99.78%
28 $7,000
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $717,312 - $1.22 Million
6,570 Added 107.72%
12,669 $1.66 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $400,948 - $1.04 Million
6,099 New
6,099 $637,000
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $187,950 - $485,629
-2,859 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $155,358 - $271,176
2,859 New
2,859 $202,000
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $3,886 - $10,480
-131 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $2,329 - $4,136
131 New
131 $4,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.